Skip to main content
Athira Pharma, Inc. logo

Athira Pharma, Inc. — Investor Relations & Filings

Ticker · ATHA ISIN · US04746L1044 LEI · 529900CSS4S4X8VY5C81 US Manufacturing
Filings indexed 398 across all filing types
Latest filing 2024-01-08 Regulatory Filings
Country US United States of America
Listing US ATHA

About Athira Pharma, Inc.

https://www.athira.com/

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecule therapeutics to address neurodegenerative diseases. The company's approach centers on creating novel compounds designed to activate the body's natural repair mechanisms to restore neuronal health and slow disease progression. These potential therapies aim to promote regeneration and provide neuroprotection. Athira's pipeline candidates are being evaluated in clinical trials to determine their safety and efficacy.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2024-01-08 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-12-29 English
SC 13D/A
Major Shareholding Notification
2023-12-29 English
10-Q
Interim / Quarterly Report Q3 2023
2023-11-09 English
8-K
Regulatory Filings
2023-11-09 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.